{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T14:57:17Z","timestamp":1793977037024,"version":"4.8.0"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2025NSFSC2166"],"award-info":[{"award-number":["2025NSFSC2166"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2023NSFSC1683"],"award-info":[{"award-number":["2023NSFSC1683"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016350","name":"Sichuan Provincial Administration of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["2024MS034"],"award-info":[{"award-number":["2024MS034"]}],"id":[{"id":"10.13039\/501100016350","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81603045"],"award-info":[{"award-number":["81603045"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82504700"],"award-info":[{"award-number":["82504700"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019649","name":"Sichuan Provincial Key Laboratory of Development and Regeneration","doi-asserted-by":"publisher","award":["24LHFYSZ1-46"],"award-info":[{"award-number":["24LHFYSZ1-46"]}],"id":[{"id":"10.13039\/501100019649","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019649","name":"Sichuan Provincial Key Laboratory of Development and Regeneration","doi-asserted-by":"publisher","award":["23LHPDZYB17"],"award-info":[{"award-number":["23LHPDZYB17"]}],"id":[{"id":"10.13039\/501100019649","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019649","name":"Sichuan Provincial Key Laboratory of Development and Regeneration","doi-asserted-by":"publisher","award":["2024GJQY01"],"award-info":[{"award-number":["2024GJQY01"]}],"id":[{"id":"10.13039\/501100019649","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017520","name":"Chengdu Medical College","doi-asserted-by":"publisher","award":["KYPY24-03"],"award-info":[{"award-number":["KYPY24-03"]}],"id":[{"id":"10.13039\/100017520","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jare.2026.03.011","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T09:48:52Z","timestamp":1773049732000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Co-delivery nanoparticle targeting CAF for simultaneous activating T cell plus NKT cell attack in solid tumor"],"prefix":"10.1016","author":[{"given":"Yucheng","family":"Xiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jare.2026.03.011_b0005","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature10673","article-title":"Cancer immunotherapy comes of age","volume":"480","author":"Mellman","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jare.2026.03.011_b0010","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/s43018-023-00600-4","article-title":"CD8+ T cells maintain killing of MHC-I-negative tumor cells through the NKG2D\u2013NKG2DL axis","volume":"4","author":"Lerner","year":"2023","journal-title":"Nat Cancer"},{"key":"10.1016\/j.jare.2026.03.011_b0015","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccell.2023.02.014","article-title":"Tumor-infiltrating regulatory Tcells as targets of cancer immunotherapy","volume":"41","author":"Tay","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jare.2026.03.011_b0020","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1038\/s41467-024-47111-z","article-title":"Cell surface patching via CXCR4-targeted nanothreads for cancer metastasis inhibition","volume":"15","author":"Zhou","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.jare.2026.03.011_b0025","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1126\/science.aaa6204","article-title":"T cell exclusion, immune privilege, and the tumor microenvironment","volume":"348","author":"Joyce","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jare.2026.03.011_b0030","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/s43018-023-00588-x","article-title":"The landscape of T cell antigens for cancer immunotherapy","volume":"4","author":"Peri","year":"2023","journal-title":"Nat Cancer"},{"key":"10.1016\/j.jare.2026.03.011_b0035","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41568-023-00560-y","article-title":"Dynamics and specificities of T cells in cancer immunotherapy","volume":"23","author":"Oliveira","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jare.2026.03.011_b0040","doi-asserted-by":"crossref","first-page":"11762","DOI":"10.1038\/ncomms11762","article-title":"Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis","volume":"7","author":"Ruhland","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.jare.2026.03.011_b0045","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.jare.2026.03.011_b0050","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41422-023-00831-1","article-title":"An invasive zone in human liver cancer identified by Stereo-seq promotes hepatocyte\u2013tumor cell crosstalk, local immunosuppression and tumor progression","volume":"33","author":"Wu","year":"2023","journal-title":"Cell Res"},{"key":"10.1016\/j.jare.2026.03.011_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122253","article-title":"Synchronous targeted delivery of TGF-\u03b2 siRNA to stromal and tumor cells elicits robust antitumor immunity against triple-negative breast cancer by comprehensively remodeling the tumor microenvironment","volume":"301","author":"Yang","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.jare.2026.03.011_b0060","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1158\/1078-0432.CCR-16-2272","article-title":"First-in-human phase i study of the oral inhibitor of indoleamine 2,3-dioxygenase-1 epacadostat (INCB024360) in patients with advanced solid malignancies","volume":"23","author":"Beatty","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jare.2026.03.011_b0065","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41392-023-01480-x","article-title":"Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets","volume":"8","author":"Yang","year":"2023","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.jare.2026.03.011_b0070","doi-asserted-by":"crossref","DOI":"10.34133\/2021\/9862876","article-title":"Responsive dual-targeting exosome as a drug carrier for combination cancer immunotherapy","volume":"2021","author":"Fan","year":"2021","journal-title":"Research"},{"key":"10.1016\/j.jare.2026.03.011_b0075","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201801868","article-title":"Tumors and their microenvironment dual-targeting chemotherapy with local immune adjuvant therapy for effective antitumor immunity against breast cancer","volume":"6","author":"Deng","year":"2019","journal-title":"Adv Sci"},{"key":"10.1016\/j.jare.2026.03.011_b0080","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202312436","article-title":"In situ engineering of tumor-associated macrophages via a nanodrug-delivering-drug (\u03b2-Elemene@Stanene) strategy for enhanced cancer chemo-immunotherapy","volume":"62","author":"Chen","year":"2023","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.jare.2026.03.011_b0085","doi-asserted-by":"crossref","first-page":"0029","DOI":"10.1038\/s41551-017-0029","article-title":"Designing nanomedicine for immuno-oncology","volume":"1","author":"Jiang","year":"2017","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.jare.2026.03.011_b0090","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.canlet.2015.10.009","article-title":"Immunotherapy and tumor microenvironment","volume":"370","author":"Tang","year":"2016","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jare.2026.03.011_b0095","article-title":"Design of calixarene-based ICD inducer for efficient cancer immunotherapy","volume":"33","author":"Zhang","year":"2023","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.jare.2026.03.011_b0100","doi-asserted-by":"crossref","first-page":"15101","DOI":"10.1073\/pnas.1213353109","article-title":"Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors","volume":"109","author":"Stylianopoulos","year":"2012","journal-title":"PNAS"},{"key":"10.1016\/j.jare.2026.03.011_b0105","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nri3902","article-title":"Immunological hallmarks of stromal cells in the tumour microenvironment","volume":"15","author":"Turley","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jare.2026.03.011_b0110","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1038\/s41416-020-1020-6","article-title":"T-cell tumour exclusion and immunotherapy resistance: a role for CAF targeting","volume":"123","author":"Hanley","year":"2020","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jare.2026.03.011_b0115","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1158\/0008-5472.CAN-19-3158","article-title":"NOX4 inhibition potentiates immunotherapy by overcoming cancer-associated fibroblast-mediated CD8 T-cell exclusion from tumors","volume":"80","author":"Ford","year":"2020","journal-title":"Cancer Res"},{"key":"10.1016\/j.jare.2026.03.011_b0120","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.3389\/fimmu.2019.01835","article-title":"The dark side of fibroblasts: cancer-associated fibroblasts as mediators of immunosuppression in the tumor microenvironment","volume":"10","author":"Monteran","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jare.2026.03.011_b0125","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1038\/s41467-018-03347-0","article-title":"Cancer-associated fibroblasts induce antigen-specific deletion of CD8+ T cells to protect tumour cells","volume":"9","author":"Lakins","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jare.2026.03.011_b0130","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.immuni.2022.12.008","article-title":"Microenvironment-driven metabolic adaptations guiding CD8+ T cell anti-tumor immunity","volume":"56","author":"Park","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.jare.2026.03.011_b0135","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.immuni.2023.06.003","article-title":"CXCR3 expression in regulatory T cells drives interactions with type I dendritic cells in tumors to restrict CD8+ T cell antitumor immunity immunity","volume":"56","author":"Moreno Ayala","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.jare.2026.03.011_b0140","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1158\/0008-5472.CAN-11-3873","article-title":"Primary tumor hypoxia recruits CD11b+\/Ly6Cmed\/Ly6G+ immune suppressor cells and compromises NK cell cytotoxicity in the premetastatic niche","volume":"72","author":"Sceneay","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.jare.2026.03.011_b0145","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00262-017-2003-1","article-title":"Tumor-associated fibrosis as a regulator of tumor immunity and response to immunotherapy","volume":"66","author":"Jiang","year":"2017","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jare.2026.03.011_b0150","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/ni1203-1164","article-title":"The NKT cell system: bridging innate and acquired immunity","volume":"4","author":"Taniguchi","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jare.2026.03.011_b0155","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1182\/blood-2003-04-1155","article-title":"Therapeutic activation of V\u03b124+V\u03b211+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity","volume":"103","author":"Nieda","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jare.2026.03.011_b0160","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.3389\/fimmu.2018.01838","article-title":"Tissue-specific roles of NKT cells in tumor immunity","volume":"9","author":"Terabe","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jare.2026.03.011_b0165","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrc.2015.5","article-title":"NK cells and cancer: you can teach innate cells new tricks","volume":"16","author":"Morvan","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jare.2026.03.011_b0170","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/ni.3518","article-title":"Targeting natural killer cells in cancer immunotherapy","volume":"17","author":"Guillerey","year":"2016","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jare.2026.03.011_b0175","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrclinonc.2016.144","article-title":"Circulating and disseminated tumour cells-mechanisms of immune surveillance and escape","volume":"14","author":"Mohme","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jare.2026.03.011_b0180","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jconrel.2024.04.052","article-title":"Alpha-galactosylceramide improves the potency of mRNA LNP vaccines against cancer and intracellular bacteria","volume":"370","author":"Meulewaeter","year":"2024","journal-title":"J Control Release"},{"key":"10.1016\/j.jare.2026.03.011_b0185","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jconrel.2023.03.010","article-title":"Oral lymphatic delivery of alpha-galactosylceramide and ovalbumin evokes anti-cancer immunization","volume":"356","author":"Pandey","year":"2023","journal-title":"J Control Release"},{"key":"10.1016\/j.jare.2026.03.011_b0190","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1158\/0008-5472.CAN-12-2130","article-title":"Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma","volume":"73","author":"Mertens","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.jare.2026.03.011_b0195","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1182\/blood-2012-04-426643","article-title":"NKT cell adjuvant-based tumor vaccine for treatment of myc oncogene-driven mouse B-cell lymphoma","volume":"120","author":"Mattarollo","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jare.2026.03.011_b0200","doi-asserted-by":"crossref","first-page":"7437","DOI":"10.1074\/jbc.M511112200","article-title":"Selective inhibition of fibroblast activation protein protease based on dipeptide substrate specificity","volume":"281","author":"Edosada","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jare.2026.03.011_b0205","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1158\/2326-6066.CIR-13-0027","article-title":"Targeting fibroblast activation protein in tumor stroma with chimeric antigen receptor T cells can inhibit tumor growth and augment host immunity without severe toxicity","volume":"2","author":"Wang","year":"2014","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.jare.2026.03.011_b0210","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1172\/JCI38988","article-title":"Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice","volume":"119","author":"Santos","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jare.2026.03.011_b0215","doi-asserted-by":"crossref","first-page":"12480","DOI":"10.1039\/c3nr04651f","article-title":"Biodegradable polymeric micelle-encapsulated quercetin suppresses tumor growth and metastasis in both transgenic zebrafish and mouse models","volume":"5","author":"Wu","year":"2013","journal-title":"Nanoscale"},{"key":"10.1016\/j.jare.2026.03.011_b0220","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ijpharm.2014.04.056","article-title":"Recent development of poly(ethylene glycol)-cholesterol conjugates as drug delivery systems","volume":"469","author":"He","year":"2014","journal-title":"Int J Pharm"},{"key":"10.1016\/j.jare.2026.03.011_b0225","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0168-3659(01)00451-5","article-title":"Long-circulating poly(ethylene glycol)\u2013poly(d,l-lactide) block copolymer micelles with modulated surface charge","volume":"77","author":"Yamamoto","year":"2001","journal-title":"J Control Release"},{"key":"10.1016\/j.jare.2026.03.011_b0230","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1039\/C8NH00417J","article-title":"DePEGylation strategies to increase cancer nanomedicine efficacy","volume":"4","author":"Kong","year":"2019","journal-title":"Nanoscale Horiz"},{"key":"10.1016\/j.jare.2026.03.011_b0235","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.clim.2010.10.005","article-title":"Anti-tumor potential of type-I NKT cells against CD1d-positive and CD1d-negative tumors in humans","volume":"140","author":"Metelitsa","year":"2011","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jare.2026.03.011_b0240","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/nrc1456","article-title":"High interstitial fluid pressure-an obstacle in cancer therapy","volume":"4","author":"Heldin","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jare.2026.03.011_b0245","first-page":"1252","article-title":"Employment of enhanced permeability and retention effect (EPR): Nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer","volume":"98","author":"Kalyane","year":"2019","journal-title":"MSE"},{"key":"10.1016\/j.jare.2026.03.011_b0250","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/anie.201506262","article-title":"Transformable peptide nanocarriers for expeditious drug release and effective cancer therapy via cancer-associated fibroblast activation","volume":"55","author":"Ji","year":"2016","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.jare.2026.03.011_b0255","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/s41467-017-02583-0","article-title":"Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer","volume":"9","author":"Fang","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jare.2026.03.011_b0260","doi-asserted-by":"crossref","first-page":"e2312","DOI":"10.1038\/cddis.2016.224","article-title":"Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts","volume":"7","author":"Baroni","year":"2016","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jare.2026.03.011_b0265","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1172\/JCI45817","article-title":"Donnadieu, matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors","volume":"122","author":"Salmon","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jare.2026.03.011_b0270","doi-asserted-by":"crossref","unstructured":"Denton AE, Roberts EW, Fearon DT. Stromal cells in the tumor microenvironment. In: B.M.J. Owens, M.A. Lakins (Eds.) Stromal Immunology, 2018, pp. 99-114.","DOI":"10.1007\/978-3-319-78127-3_6"},{"key":"10.1016\/j.jare.2026.03.011_b0275","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nri2607","article-title":"Interdependence of hypoxic and innate immune responses","volume":"9","author":"Nizet","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jare.2026.03.011_b0280","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nri1685","article-title":"Regulation of immune cells by local-tissue oxygen tension: HIF1\u03b1 and adenosine receptors","volume":"5","author":"Sitkovsky","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jare.2026.03.011_b0285","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cell.2005.02.034","article-title":"Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1\/CXCL12 secretion","volume":"121","author":"Orimo","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.jare.2026.03.011_b0290","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.it.2010.04.002","article-title":"TGF-\u03b2 and immune cells: an important regulatory axis in the tumor microenvironment and progression","volume":"31","author":"Yang","year":"2010","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jare.2026.03.011_b0295","doi-asserted-by":"crossref","unstructured":"Cheng JT, Deng YN, Yi HM, Wang GY, Fu BS, Chen WJ, et al. Hepatic carcinoma-associated fibroblasts induce IDO-producing regulatory dendritic cells through IL-6-mediated STAT3 activation, Oncogenesis, 5 (2016) e198-e198.","DOI":"10.1038\/oncsis.2016.7"},{"key":"10.1016\/j.jare.2026.03.011_b0300","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/sj.icb.7100116","article-title":"TGF\u03b2 is responsible for skin tumour infiltration by macrophages enabling the tumours to escape immune destruction","volume":"86","author":"Byrne","year":"2008","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.jare.2026.03.011_b0305","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.addr.2015.11.009","article-title":"Tumor-associated macrophages: potential therapeutic targets for anti-cancer therapy","volume":"99","author":"Komohara","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jare.2026.03.011_b0310","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1158\/1078-0432.CCR-13-2972","article-title":"Prevailing role of contact guidance in intrastromal T-cell trapping in human pancreatic cancer","volume":"20","author":"Hartmann","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jare.2026.03.011_b0315","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.2703","article-title":"Innate and adaptive immune cells in the tumor microenvironment","volume":"14","author":"Gajewski","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jare.2026.03.011_b0320","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1172\/JCI37869","article-title":"V\u03b124-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages","volume":"119","author":"Song","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jare.2026.03.011_b0325","first-page":"1655","article-title":"Broadening the message: a nanovaccine co-loaded with messenger RNA and \u03b1-GalCer induces antitumor immunity through conventional and natural killer T cells","volume":"13","author":"Verbeke","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jare.2026.03.011_b0330","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00262-019-02363-3","article-title":"Mouse CD8+NKT-like cells exert dual cytotoxicity against mouse tumor cells and myeloid-derived suppressor cells","volume":"68","author":"Li","year":"2019","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jare.2026.03.011_b0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/intimm\/dxp104","article-title":"The specialized iNKT cell system recognizes glycolipid antigens and bridges the innate and acquired immune systems with potential applications for cancer therapy","volume":"22","author":"Taniguchi","year":"2010","journal-title":"Int Immunol"},{"key":"10.1016\/j.jare.2026.03.011_b0340","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1158\/0008-5472.CAN-14-3619","article-title":"Radiotherapy combined with novel STING-targeting oligonucleotides results in regression of established tumors","volume":"76","author":"Baird","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.jare.2026.03.011_b0345","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/nm.3915","article-title":"Toward understanding and exploiting tumor heterogeneity","volume":"21","author":"Alizadeh","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.jare.2026.03.011_b0350","doi-asserted-by":"crossref","first-page":"13193","DOI":"10.1038\/ncomms13193","article-title":"Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy","volume":"7","author":"Chen","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.jare.2026.03.011_b0355","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal3765","article-title":"Targeted apoptosis of myofibroblasts with the BH3 mimetic ABT-263 reverses established fibrosis","volume":"9","author":"Lagares","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jare.2026.03.011_b0360","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrc1670","article-title":"Breast cancer metastasis: markers and models","volume":"5","author":"Weigelt","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jare.2026.03.011_b0365","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrc1877","article-title":"Fibroblasts in cancer","volume":"6","author":"Kalluri","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jare.2026.03.011_b0370","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nature03096","article-title":"Stromal fibroblasts in cancer initiation and progression","volume":"432","author":"Bhowmick","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.jare.2026.03.011_b0375","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1111\/j.1349-7006.2010.01695.x","article-title":"Immunotherapy targeting fibroblast activation protein inhibits tumor growth and increases survival in a murine colon cancer model","volume":"101","author":"Wen","year":"2010","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jare.2026.03.011_b0380","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1200\/JCO.2014.60.0379","article-title":"Toxicities of immunotherapy for the practitioner","volume":"33","author":"Weber","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jare.2026.03.011_b0385","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1002\/1521-4141(200007)30:7<1919::AID-IMMU1919>3.0.CO;2-3","article-title":"Activation of hepatic NKT cells and subsequent liver injury following administration of \u03b1-galactosylceramide","volume":"30","author":"Osman","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jare.2026.03.011_b0390","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1007\/s10620-005-2949-2","article-title":"Therapeutic effect of repeated natural killer T cell stimulation in mouse cholangitis complicated by colitis","volume":"50","author":"Numata","year":"2005","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jare.2026.03.011_b0395","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cyto.2018.08.032","article-title":"Natural killer T cell ligand alpha-galactosylceramide protects against gut ischemia reperfusion-induced organ injury in mice","volume":"111","author":"Zhang","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.jare.2026.03.011_b0400","doi-asserted-by":"crossref","first-page":"16014","DOI":"10.1038\/natrevmats.2016.14","article-title":"Analysis of nanoparticle delivery to tumours","volume":"1","author":"Wilhelm","year":"2016","journal-title":"Nat Rev Mater"},{"key":"10.1016\/j.jare.2026.03.011_b0405","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202003563","article-title":"Immunomodulation-enhanced nanozyme-based tumor catalytic therapy","volume":"32","author":"Xu","year":"2020","journal-title":"Adv Mater"},{"key":"10.1016\/j.jare.2026.03.011_b0410","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/btm2.10003","article-title":"Nanoparticles in the clinic","volume":"1","author":"Anselmo","year":"2016","journal-title":"Bioeng Transl Med"},{"key":"10.1016\/j.jare.2026.03.011_b0415","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/nrclinonc.2010.38","article-title":"Conscripts of the infinite armada: systemic cancer therapy using nanomaterials","volume":"7","author":"Scheinberg","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jare.2026.03.011_b0420","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s40820-020-00495-1","article-title":"A combinative assembly strategy inspired reversibly borate-bridged polymeric micelles for lesion-specific rapid release of anti-coccidial drugs","volume":"12","author":"Cheng","year":"2020","journal-title":"Nano-Micro Lett"},{"key":"10.1016\/j.jare.2026.03.011_b0425","doi-asserted-by":"crossref","first-page":"7812","DOI":"10.1021\/acsnano.8b01890","article-title":"Nanocarrier-mediated chemo-immunotherapy arrested cancer progression and induced tumor dormancy in desmoplastic melanoma","volume":"12","author":"Liu","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jare.2026.03.011_b0430","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.3390\/cancers7040902","article-title":"Cancer-associated fibroblasts: their characteristics and their roles in tumor growth","volume":"7","author":"Shiga","year":"2015","journal-title":"Cancers"},{"key":"10.1016\/j.jare.2026.03.011_b0435","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2217\/iim.12.20","article-title":"Intravascular multispectral optoacoustic tomography of atherosclerosis: prospects and challenges","volume":"4","author":"Rosenthal","year":"2012","journal-title":"Imaging Med"},{"key":"10.1016\/j.jare.2026.03.011_b0440","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.7150\/thno.19841","article-title":"Oxygen enhanced optoacoustic tomography (OE-OT) reveals vascular dynamics in murine models of prostate cancer","volume":"7","author":"Tomaszewski","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.jare.2026.03.011_b0445","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1158\/0008-5472.CAN-14-2522","article-title":"Mesoscopic and macroscopic optoacoustic imaging of cancer","volume":"75","author":"Taruttis","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.jare.2026.03.011_b0450","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1148\/radiol.11111646","article-title":"Optical imaging of cancer heterogeneity with multispectral optoacoustic tomography","volume":"263","author":"Herzog","year":"2012","journal-title":"Radiology"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123226002316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123226002316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T04:56:47Z","timestamp":1776142607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123226002316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":90,"alternative-id":["S2090123226002316"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2026.03.011","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Co-delivery nanoparticle targeting CAF for simultaneous activating T cell plus NKT cell attack in solid tumor","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2026.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}